And now, a three-part, six-hour documentary series based on Siddhartha Mukherjee’s book “The Emperor of All Maladies: A Biography of Cancer” debuts on PBS stations March 30 and continues on March 31 and April 1.
The drug Gleevec (imatinib mesylate) is well known not only for its effectiveness against chronic myeloid leukemia (CML) and acute lymphoblastic leukemia, but also for the story behind its development.
Thomson Reuters Corporation, a mass media and information firm well known for publishing the impact factors of scientific journals, has named 11 CUMC scientists to its list of the world’s most influential scientific minds of 2014.
Andreas Hielscher, professor of biomedical engineering, electrical engineering, and of radiology (physics) is developing a novel technology that could improve diagnosis of this crippling disease and make it easier to monitor patients.
David D. Yao, the Piyasombatkul Family Professor of Industrial Engineering and Operations Research, has been elected to the National Academy of Engineering (NAE), one of the highest professional distinctions awarded to an engineer.